glp 1 agonist for prediabetes GLP-1 Prevention: Using Drugs Like Zepbound for Pre-Diabetes or Metabolic Risk -What Does Research Say? GLP1 Receptor Agonists—Effects beyond Obesity

Worsening of HF in the group of patients receiving dapagliflozin was 23% lower

The GLP-1 drug Wegovy for weight issues or obesity is approved for individuals with a BMI of 26-plus and co-morbidities, or those with a BMI of 30-plus

First, a quick refresher on what a GLP-1 receptor agonist is: one of the most popular GLP-1 receptor agonists is Ozempic, a semaglutide medication that's technically designed to help control blood sugar in people with type 2 diabetes

One benefit of GLP-1 receptor agonists is that they do not cause hypoglycemia when combined with metformin or thiazolidinediones, but the dose of concomitant sulphonylurea or insulin may have to be decreased to reduce the risk of hypoglycemic episodes

10.2174/1573399810666140707092506 [DOI] [PubMed] [Google Scholar] 20

JAMA (2016) 315:2424